| HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
C9orf47 |
EDG3: Sphingosine 1-phosphate receptor Edg-3 |
6.11 |
Evidence |
|
| HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
RXFP4 |
RXFP4, GPR100, RLN3R2: Relaxin-3 receptor 2 |
6.11 |
Evidence |
|
| HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
XCR1 |
XCR1, CCXCR1, GPR5: Chemokine XC receptor 1 |
6.11 |
Evidence |
|
| RPA1 |
RPA1, REPA1, RPA70: Replication protein A 70 kDa DNA-binding subunit |
RPA3 |
RPA3, REPA3, RPA14: Replication protein A 14 kDa subunit |
6.11 |
Evidence |
O
|
| U2AF2 |
U2AF2, U2AF65: Splicing factor U2AF 65 kDa subunit |
ZCCHC7 |
ZCCHC7, HSPC086: Zinc finger CCHC domain-containing protein 7 |
6.11 |
Evidence |
|
| U2AF2 |
U2AF2, U2AF65: Splicing factor U2AF 65 kDa subunit |
CIRBP |
CIRBP, A18HNRNP, CIRP: Cold-inducible RNA-binding protein |
6.11 |
Evidence |
|
| PSMA4 |
PSMA4, PSC9: Proteasome subunit alpha type-4 |
PRKACB |
PRKACB: cAMP-dependent protein kinase, beta-catalytic subunit |
6.11 |
Evidence |
|
| PSMA4 |
PSMA4, PSC9: Proteasome subunit alpha type-4 |
MAPKAPK5 |
IPI00160672 |
6.11 |
Evidence |
|
| PSMA4 |
PSMA4, PSC9: Proteasome subunit alpha type-4 |
MAP2K5 |
IPI00219607 |
6.11 |
Evidence |
|
| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
RPA3 |
RPA3, REPA3, RPA14: Replication protein A 14 kDa subunit |
6.11 |
Evidence |
|
| TBXA2R |
TBXA2R: Thromboxane A2 receptor |
HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
6.11 |
Evidence |
|
| CNR1 |
CNR1, CNR: Cannabinoid receptor 1 |
HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
6.11 |
Evidence |
|
| EFNA1 |
EFNA1, EPLG1, LERK1, TNFAIP4: Ephrin-A1 precursor |
NELL2 |
NELL2, NRP2: Protein kinase C-binding protein NELL2 precursor |
6.11 |
Evidence |
|
| RHOQ |
RHOQ, ARHQ, RASL7A, TC10: Rho-related GTP-binding protein RhoQ precursor |
PARD6G |
PARD6G, PAR6G: Partitioning defective 6 homolog gamma |
6.11 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
KIR2DL3 |
KIR2DL3, CD158B2, KIRCL23, NKAT2: Killer cell immunoglobulin-like receptor 2DL3 |
6.11 |
Evidence |
|
| BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
RASGRF1 |
RASGRF1, CDC25: Guanine nucleotide-releasing protein |
6.11 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
RASGRF1 |
RASGRF1, CDC25: Guanine nucleotide-releasing protein |
6.11 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
BTLA |
BTLA: B- and T-lymphocyte attenuator precursor |
6.11 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PLEKHA4 |
PLEKHA4, PEPP1: Pleckstrin homology domain-containing family A member 4 |
6.11 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
OSTF1 |
IPI00333434 |
6.11 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
NCF2 |
NCF2: Neutrophil cytosol factor 2 |
6.11 |
Evidence |
|
| SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
PRRG4 |
PRRG4, TMG4: Transmembrane gamma-carboxyglutamic acid protein 4 precursor |
6.11 |
Evidence |
|
| SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
KREMEN2 |
KREMEN2, KRM2: Kremen protein 2 precursor |
6.11 |
Evidence |
|
| DNTT |
DNTT, TDT: DNA nucleotidylexotransferase |
MSH6 |
MSH6, GTBP: DNA mismatch repair protein MSH6 |
6.11 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
RASGRF1 |
RASGRF1, CDC25: Guanine nucleotide-releasing protein |
6.11 |
Evidence |
|